Skip to main content

OptimizeRx Corp

OPRX
Exchange
Nasdaq
Industry
Services-Business Services, NEC
SEC CIK
0001448431

No open-market purchases or sales by OptimizeRx Corp insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $64.2M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding OptimizeRx Corp changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of OPRX: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders9897−1
Shares12.5M12.8M+289.0K (+2.3%)
Value$178.8M$155.4M−$23.4M (−13.1%)

New holders (16)

Institutions that held OptimizeRx Corp at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to OPRX in Q1 2024
InstitutionSharesValue% of portfolio
Essex Investment Management Co LLC86,656$1.05M0.21%
Mirae Asset Global Investments Co., Ltd.44,576$626.7K0.00%
Legato Capital Management LLC34,316$416.9K0.05%
Jane Street Group, LLC28,155$342.1K0.00%
Invesco Ltd.22,115$268.7K0.00%
Jump Financial, LLC18,638$226.5K0.01%
Premier Fund Managers Ltd15,511$188.0K0.01%
ExodusPoint Capital Management, LP11,341$138.0K0.00%
Group One Trading, L.P.11,218$136.3K0.00%
Catalyst Funds Management Pty Ltd11,150$135.5K0.04%
Qube Research & Technologies Ltd8,251$100.3K0.00%
US Bancorp304$3.69K0.00%
Creative Financial Designs Inc191$2.32K0.00%
The PNC Financial Services Group, Inc.54$6560.00%
Point72 (DIFC) Ltd35$4250.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC4$480.00%

Sold out (17)

Institutions that held OptimizeRx Corp at the end of Q4 2023 and filed for Q1 2024 without it.